<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Mechanism of freeze-induced protein destabilization Experiment number</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><surname>Ls-2601</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andy</forename><surname>Fitch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Elena</forename><surname>Boldyreva</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Xin</forename><surname>Wen</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Institute of Solid State Chemistry SB RAS</orgName>
								<address>
									<addrLine>Kutateladze Street, 18</addrLine>
									<settlement>Novosibirsk</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Boris Zakharov</orgName>
								<orgName type="department" key="dep2">Institute of Solid State Chemistry and Mech. Department of Reactivity of Solids</orgName>
								<address>
									<addrLine>Kutateladze str. 18</addrLine>
									<settlement>Novosibirsk</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Alexander Fisyuk</orgName>
								<orgName type="department" key="dep2">Chemistry Department</orgName>
								<orgName type="laboratory">Laboratory of Organic Synthesis</orgName>
								<orgName type="institution">Omsk F.M. Dostoevsky State University</orgName>
								<address>
									<addrLine>Prospect Mira 55a</addrLine>
									<settlement>Omsk</settlement>
									<country key="RU">Russia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">Bakul Bhatnagar</orgName>
								<orgName type="institution">Pfizer, Inc. BTx PharmSci Pharmaceutical R&amp;D</orgName>
								<address>
									<addrLine>One Burtt Road</addrLine>
									<settlement>Andover</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Iurii Seretkin</orgName>
								<orgName type="department" key="dep2">Institute of Geology and Mineralogy RAS</orgName>
								<address>
									<addrLine>Ac.Koptyuga Ave. 3</addrLine>
									<settlement>Novosibirsk</settlement>
									<country key="RU">Russian Federation</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Andy Fitch</orgName>
								<orgName type="laboratory">The European Synchrotron Radiation Facility</orgName>
								<address>
									<addrLine>71 av des Martyrs</addrLine>
									<postCode>38043</postCode>
									<settlement>Grenoble</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Department of Chemistry and Biochemistry</orgName>
								<orgName type="institution">California State University</orgName>
								<address>
									<settlement>Los Angeles</settlement>
									<region>CA</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Pharmaceutical Development</orgName>
								<orgName type="institution">Evgenyi Shalaev</orgName>
								<address>
									<addrLine>Allergan plc 2525 Dupont Dr</addrLine>
									<settlement>Irvine</settlement>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Mechanism of freeze-induced protein destabilization Experiment number</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">9B58BDF91EADCC1EA03A833C83ACAD11</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T12:34+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>The primary objective of the study is to investigate solute/ice interaction using high-resolution X-ray diffraction. This data will be used to evaluate impact of solutes on ice recrystallization, and also get an insight into protein/ice interaction. Both of these topics are of primary interest for both applied (e.g., pharmaceutical science and technology) and fundamental science.</p><p>The main part of the experiment was devoted to aqueous solutions containing typical pharmaceutical solutes, including buffer (histidine), cryoprotector (sucrose), surfactant (polysorbate PS80), and four different proteins. The proteins are selected to cover a wide range of the isoelectric points, pI, from 4.7 to 11.35, and to represent different classes in terms of their applications. In particular, antifreeze protein (AFP), a monoclonal antibody (representing the most common type of protein drugs), lysozyme (the most common model protein), and recombinant humanized albumin are studied. Use of proteins of different pIs would allow us to evaluate role of electrostatics in protein/ice interaction. The X-ray diffraction patterns are collected at three sub-zero temperatures, i.e., 100 K, 228 K, and 258 K. Annealing is used to follow ice recrystallization as a function of time and temperature, and also to monitor amorphous/crystalline structure of solutes, in particular the buffer.</p><p>The list of samples tested is given in Table <ref type="table" target="#tab_0">1</ref>, along with the information of the number of scans performed and thermal conditions. In order to perform the initial data analysis, the background subtraction (using the data obtained for empty capillaries) has been assessed. For the background subtraction, the corresponding empty capillary pattern is subtracted from a particular dataset, e.g., "empty1" run 1 at 100K is subtracted from water 100K run 1, empty1 100K run 2 is subtracted from water 100K run2, etc. Examples of patterns with and without background subtraction are shown in Fig. <ref type="figure" target="#fig_0">1</ref>. Considering that the background's contribution to the diffraction intensities is minor, further data analysis is performed without subtraction of the background scattering.</p><p>Examples of the patterns for water and AFP samples at 100K are provided in Fig 2 . In the experimental ice pattern, all hexagonal ice (Ih) peaks are observed, while their relative intensities are significantly different from those in the theoretical pattern. The difference between theoretical and experimental intensities is probably due to randomly-enhanced growth of particular crystal faces. The relative intensities of the peaks in the presence of AFP are much closer to the theoretical intensities than those in pure water. However, several peaks in all three AFP samples have consistently lower intensites, as compared to the theoretical pattern of Ih, in particular 002 and 110, 200, 105 peaks. X-ray diffraction patterns for pure water and AFP solutions at 228K are presented in Fig 3 . There is no significant difference between 1 st and 11 th scans for water, while certain changes in the relative peak intesitites for AFP samples are noted. At 258K, some decrease in the peak intensities between run 1 and 11 is observed for water and AFP-water samples, but not AFP-histidine soluiton <ref type="bibr">(Fig 4)</ref>.</p><p>Examples of XRD patterns of solutions containing sucrose and two proteins are shown in Fig <ref type="figure">5</ref> and <ref type="figure" target="#fig_3">6</ref>. All peaks of Ih are observed in these samples, although the relative intensities are different between different samples and are generally not the same as the theoretical intensities.</p><p>An important practical aspect of the study is an ability to accurately measure the local temperature on ice/solution interface. Taking into account that the sample temperature might not be exactly the same as the thermostat temperature (due to irradation-induced heating), the potential effect of the irradiation-induced heating is evaluated by measuring ice lattice parameters with and without full power, using an intensity attentuation factor of 5. In addition, patterns of pure ice, which are recorded at three different temperatures, will be used to evaluate the contribution of the thermal diffuse scattering form ice crystals to the scattering from the amorphous freeze-concentrated solution in proteni and sucrose samples.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion.</head><p>The preliminary analysis of the data indicate that AFP inhibits growth of ice crystals in the direcitons corresponding to hkl 002, 110, 200, and 105. In addition, short-term annealing at 258K results in decreased intensity of diffraction peaks of Ih in water and water-AFP samples, which is unexpected and needs to be further evaluated. These observation should be considered as tentative, to be confirmed in a more systematic data analysis involving all 11 runs for each sample at different temperatures. Finally, contributions of the microstrain and crystallite size to the peak broadening will be eveluated using Williamson-Hall relationship.  10 20 30 40 0 50 100 Relative intensity 2theta Normalize to [0, 100] of "water 100K run1" ice theoretical, -183C 10 20 30 40 0 50 100 ice theoretical, -183C Normalize to [0, 100] of "AFP 0.5 mg/ml 100K-1" Normallized intensity 2theta, deg 5 10 15 20 25 30 0 50 100 ice theoretical, -183C Normalize to [0, 100] of "AFP-his 1 mg/ml, 100K, run 1" Normallized intensity 2theta, deg 215 310 220 205 006 213 300 105 211 210 203 202 201 200 112 103 110 102 101 100 002 10 20 30 40 0 50 100 Normallized intensity 2theta, deg Normalize to [0, 100] of "AFP 1 mg/ml 100K, run 1" ice theoretical, -183C Fig. 2. X-ray diffraction patterns of pure water, AFP-water, and AFP-histidine samples at 100 K for first scans, with the background subtracted. Theoretical pattern for hexagonal ice at -183 °C is also shown.</p><p>7 8 9 10 11 0 20000 40000 60000 80000 10 20 30 0 50000 100000 5 10 15 20 25 30 0 50000 100000 150000 200000 250000 5 10 15 20 25 30 0 20000 40000 60000 80000 100000 120000</p><p>Intensity 2theta, deg AFP 1 mg/ml, 228K, run 1 AFP 1 mg/ml, 228K, run 11 2theta, deg AFP 1 mg/ml HIS, 228K, run 1 AFP 1mg/ml HIS, 228K, run 11 Intensity 2theta, deg AFP 0.5 mg/ml, 228K, run 1 AFP 0.5 mg/ml, 228K, run 11 2theta, deg water, 228K, 1st run water, 228K, run 11 10 20 30 0 20000 40000 60000 80000 100000 120000 10 20 30 0 50000 100000 150000 200000 10 20 30 0 20000 40000 60000 80000 100000 120000 5 10 15 20 25 30 20000 40000 60000 80000 100000 Intensity 2theta, deg water 258K run 1 water 258K run 11 Intensity 2theta, deg AFP 0.5 mg/ml, 258 K, run 1 AFP 0.5 mg/ml, 258 K, run 11 Intensity 2theta, deg AFP 1 mg/ml, HIS, 258K, run 1 AFP 1 mg/ml, HIS, 258K, run 11 Intensity 2theta, deg AFP 1 mg/ml 258K run 1 AFP 1 mg/ml 258K run 11 Fig. 4. X-ray diffraction patterns (no background subtraction) for AFP and pure water samples at 258K, run 1 and 11 Figure 5. X-ray diffraction patterns sucrose solutions at 100 K (first scan; unannealed) and 258 K (last or 11 th scan at 258K; annealed). </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Examples of X-ray diffraction patterns with and without background subtraction at 100K</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .Fig. 4 .</head><label>34</label><figDesc>Fig. 3. X-ray diffraction patterns (no background subtraction) for AFP and pure water samples at 228K, run 1 and 11</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 6 .</head><label>6</label><figDesc>Figure 6. X-ray diffraction patterns for protein solutions at 100 K (first scan; unannealed) and 258 K (last or 11 th scan at 258K; annealed).</figDesc><graphic coords="10,33.95,65.15,470.75,477.85" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><graphic coords="9,33.95,36.85,527.40,446.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>List of the samples studied and experimental conditions.</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>100K</cell><cell></cell><cell>228K</cell><cell></cell><cell>258K</cell></row><row><cell>#</cell><cell>Sample</cell><cell>Anneali</cell><cell># of</cell><cell>Annealin</cell><cell># of</cell><cell>Anneali</cell><cell># of</cell></row><row><cell></cell><cell>description</cell><cell>ng: Yes</cell><cell>consecutive</cell><cell>g: Yes /</cell><cell>consecutive</cell><cell>ng: Yes</cell><cell>consecutive</cell></row><row><cell></cell><cell></cell><cell>/ No</cell><cell>scans at this</cell><cell>No</cell><cell>scans at this</cell><cell>/ No</cell><cell>scans at this</cell></row><row><cell></cell><cell></cell><cell></cell><cell>temperature</cell><cell></cell><cell>temperature</cell><cell></cell><cell>temperature</cell></row><row><cell>1</cell><cell>Water</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell>2</cell><cell>Water -5X</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell></row><row><cell></cell><cell>attenuated beam</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>3</cell><cell>5% w/v Sucrose</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>in water</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>4</cell><cell>10% w/v Sucrose</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>in water</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>5</cell><cell>20% w/v Sucrose</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>in water</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>6</cell><cell>0.5 mg/mL AFP</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>in water</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>7</cell><cell>1.0 mg/mL AFP</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>in water</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>8</cell><cell>1.0 mg/mL AFP</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>in 20 mM His</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>buffer, pH 5.8</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>9</cell><cell>20 mM Histidine</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell></row><row><cell></cell><cell>buffer + 5% w/v</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Sucrose, pH 5.8</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>10</cell><cell>20 mM Histidine</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell></row><row><cell></cell><cell>buffer + 5% w/v</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Sucrose + 0.02%</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>w/v PS80, pH 5.8</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>11</cell><cell>100 mg/mL IgG1</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>mAb + 20 mM</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Histidine buffer,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>pH 5.8</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>12</cell><cell>100 mg/mL IgG1</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>mAb + 20 mM</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Histidine buffer +</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>5% w/v Sucrose +</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>0.02% w/v PS80,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>pH 5.8</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>13</cell><cell>100 mg/mL rHA</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>+ 20 mM</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Histidine buffer,</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>pH 5.8</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>14</cell><cell>100 mg/mL</cell><cell>No</cell><cell>4</cell><cell>Yes</cell><cell>11</cell><cell>Yes</cell><cell>11</cell></row><row><cell></cell><cell>Lysozyme + 20</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>mM Histidine</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>buffer, pH 5.8</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell cols="2">15 Empty capillary-1</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell><cell>No</cell><cell>4</cell></row><row><cell cols="2">16 Empty capillary-2</cell><cell>No</cell><cell>0</cell><cell>No</cell><cell>0</cell><cell>No</cell><cell>4</cell></row></table></figure>
		</body>
		<back>
			<div type="references">

				<listBibl/>
			</div>
		</back>
	</text>
</TEI>
